REFERENCES
- Tossani E, Cassano P, Fava M. Depression and renal disease. Semin Dial. 2005;18:73–81.
- Wuerth D, Finkelstein SH, Finkelstein FO. The identification and treatment of depression in patients maintained on dialysis. Semin Dial. 2005;18:142–146.
- Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7:198–207.
- Chung SH, Lindholm B, Lee HB. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int. 2000;20:19–26.
- Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis. 2000;36:1213–1225.
- Cueto-Manzano AM, González-Espinoza L, Martin del Campo F, Fortes PC, Pecoits-Filho R. Inflammation in peritoneal dialysis: a Latin-American perspective. Perit Dial Int. 2007;27(3):347–352.
- Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol. 2004;500:399–411.
- Panichi V, Migliori M, De Pietro S, . C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif. 2000;18:30–36.
- Panagiotakos DB, Pitsavos C, Chrysohoou C, . Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004;25:492–499.
- Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand. 1998;97:309–313.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
- Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–169.
- Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–296.
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.
- Detsky AS, McLaughlin JR, Baker JP, . What is subjective global assessment of nutritional status? J Parenter Enteral Nutr. 1987;11:8–13.
- Li Y, Dong J, Zuo L. Is subjective global assessment a good index of nutrition in peritoneal dialysis patients with gastrointestinal symptoms? Perit Dial Int. 2009;29(2):78–82.
- Prasad N, Gupta A, Sinha A, Sharma RK, Kumar A, Kumar R. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J Ren Nutr. 2008;18:195–201.
- Borazan A, Üstün H, Üstündag Y, . The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factör-alpha, interleukin-6, interleukin-10 and C-reactive protein levels. Mediators Inflamm. 2004;13:201–214.
- Wuerth D, Finkelstein SH, Kliger AS, Finkelstein FO. Chronic peritoneal dialysis patients diagnosed with clinical depression: results of pharmacologic therapy. Semin Dial. 2003;16:424–427.
- Atalay H, Solak Y, Biyik M, . Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients. Int Urol Nephrol. 2010;42(2):527–536.
- Kalender B, Özdemir AC, Köroğlu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract. 2006;102:115–121.
- Einwohner R, Bernerdini J, Piraino B. The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int. 2004;24:256–263.
- O’Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol. 2004;19(6):397–403.
- Barros A, da Costa BE, Poli-de-Figueiredo CE, Antonello IC, d’Avila DO. Nutritional status evaluated by multi-frequency bioimpedance is not associated with quality of life or depressive symptoms in hemodialysis patients. Ther Apher Dial. 2011;15(1):58–65.
- Kalender B, Dervisoglu E, Sengul E, . Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: is there a relationship? Perit Dial Int. 2007;27:593–595.
- Li ZJ, An X, Mao HP, . Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol. 2011;43:215–224.
- Sonikian M, Metaxaki P, Papavasileiou D, . Effects of interleukin-6 on depression risk in dialysis patients. Am J Nephrol. 2010;31(4):303–308.
- Ko GJ, Kim MG, Yu YM, Jo SK, Cho WY, Kim HK. Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis. Nephron Clin Pract. 2010;116(1):29–35.
- McRae AL, Brady KT. Review of sertraline and its clinical applications in psychiatric disorders. Expert Opin Pharmacother. 2001;2:883–892.
- Kubera M, Simbirtsev A, Mathison R, Maes M. Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiat Res. 2000;96:255–266.
- Lee SK, Lee HS, Lee TB, . The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients. J Korean Med Sci. 2004;19:384–389.
- Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci. 1997;247:228–233.